NPC-Nivo Nivolumab in combination with cisplatin and 5-fluorouracil as induction therapy in children and adults with EBV-positive nasopharyngeal carcinoma (Aktiv)
Zweitlinie oder später
IFX-1-P2.8 Phase II Studie zu IFX-1 als Zweitlinientherapie bei fortgeschrittenem/metastasiertem Plattenepithelkarzinom der Haut (Aktiv)
PaceAce Paclitaxel plus cetuximab for the treatment of recurrent and/or metastatic head and neck cancer after first-line checkpoint inhibitor failure: A multicenter, single arm study (Aktiv)
R2810-ONC-1788 Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma (Aktiv)
RAMOS Study With Paclitaxel +/- Ramucirumab in Patients With Squamous-cell Carcinoma of the Esophagus After Prior Therapy (RAMOS) (Aktiv)